Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
---|---|---|---|---|---|---|---|---|
CancerPDF_ID964 | NA | NA | Serum | 7772.38 | MALDI-TOF | Colorectal cancer | Upregulated and considered as candidate biomarker | 23091368 |
CancerPDF_ID1168 | NA | NA | Serum | 7763.77 | MALDI-TOF | Lung cancer | Downregulated in cancer vs normal with average expression of peptide in cancer 2.86 and in normal 9.82 | 21082738 |
CancerPDF_ID1170 | NA | NA | Serum | 7952.52 | MALDI-TOF | Lung cancer | Downregulated in cancer vs normal with average expression of peptide in cancer 0.42 and in normal 0.68 | 21082738 |
CancerPDF_ID1174 | NA | NA | Serum | 7563.89 | MALDI-TOF | Lung cancer | Downregulated in cancer vs normal with average expression of peptide in cancer 0.35 and in normal 0.49 | 21082738 |
CancerPDF_ID1183 | NA | NA | Serum | 7651.7 | MALDI-TOF | Lung cancer | Downregulated in cancer vs normal with average expression of peptide in cancer 0.4 and in normal 0.67 | 21082738 |
CancerPDF_ID1192 | NA | NA | Serum | 7007.68 | MALDI-TOF | Lung cancer | Downregulated in cancer vs normal with average expression of peptide in cancer 0.59 and in normal 0.72 | 21082738 |
CancerPDF_ID3271 | NA | NA | Serum | 7772.1 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
CancerPDF_ID3325 | NA | NA | Serum | 7476.7 | MALDI-TOF | Ovarian cancer | Differentially expressed between normal and patients | 22086897 |
CancerPDF_ID3338 | NA | NA | Serum | 7763.24 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3341 | NA | NA | Serum | 7563.83 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3343 | NA | NA | Serum | 7920.5 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3351 | NA | NA | Serum | 7468.37 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3372 | NA | NA | Serum | 7007.25 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3374 | NA | NA | Serum | 7651.87 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID8416 | NA | NA | Serum | 7740.77 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | Frequency of peptide In lung cancer : 85.71% ; In Rectal cancer : 97.22% ; Breast cancer: 98%; In normal healthy individuals : 95.2% | 23667664 |
CancerPDF_ID8493 | NA | NA | Serum | 7458.63 | MALDI-TOF | "Breast cancer, Lung cancer, Rectal cancer" | "Frequency of peptide in rectal cancer : 41.67% , In normal healthy individuals : 5.2%" | 23667664 |
CancerPDF_ID8657 | NA | NA | Serum | 7637.05 | MALDI-TOF | "Hepatocellular carcinoma, Liver cirrhosis, Chronic hepatitis" | significantly different from that of normal | 23915185 |
CancerPDF_ID12768 | NA | NA | Serum | 7773 | MALDI-TOF | Cervical cancer | Upregulated in Cervical squamous cell carcinoma vs healthy | 26282206 |
CancerPDF_ID12769 | NA | NA | Serum | 7643.01 | MALDI-TOF | Hepatocellular carcinoma | Downregulated in cancer vs Healthy | 25910294 |
CancerPDF_ID12770 | NA | NA | Serum | 7927.69 | MALDI-TOF | Hepatocellular carcinoma | Downregulated in cancer vs Healthy | 25910294 |
CancerPDF_ID12771 | NA | NA | Serum | 7833.44 | MALDI-TOF | Hepatocellular carcinoma | Downregulated in cancer vs Healthy | 25910294 |
CancerPDF_ID12773 | NA | NA | Serum | 7771.17 | MALDI-TOF | Hepatocellular carcinoma | Downregulated in cancer vs Healthy | 25910294 |
CancerPDF_ID12775 | NA | NA | Serum | 7896.09 | MALDI-TOF | Hepatocellular carcinoma | Downregulated in cancer vs Healthy | 25910294 |
CancerPDF_ID12805 | NA | NA | Serum | 7788.6 | MALDI-TOF | Colorectal adenoma and Colorectal carcinoma | "Differential Peptide Peaks in Colorectal Cancer, Colorectal Adenoma and Health Volunteer Group" | 24289627 |
CancerPDF_ID12823 | NA | NA | Serum | 7769.65 | MALDI-TOF | Colorectal adenoma and Colorectal carcinoma | "Differential Peptide Peaks in Colorectal Cancer, Colorectal Adenoma and Health Volunteer Group" | 24289627 |
CancerPDF_ID14325 | NA | NA | Serum | 7822.5 | Magnetic bead based weak cation exchange chromatography(MB-WCX) | Gastric cancer | NA | 21739109 |
CancerPDF_ID14355 | NA | NA | Serum | 7772.04 | IMAC-MB | Breast cancer | NA | 22521044 |
CancerPDF_ID14356 | NA | NA | Serum | 7777.16 | IMAC-MB | Breast cancer | NA | 22521044 |
CancerPDF_ID14358 | NA | NA | Serum | 7637.05 | MB-WCX | Hepatocellular carcinoma | NA | 23915185 |